Skip To Main Content
This website is intended exclusively for the healthcare professionals residing and/or working in Malaysia.
Campus
Campus

Northern Hemisphere 2023 - 2024 Influenza Strain Change

The World Health Organization (WHO) recommends influenza vaccine strains for use in the northern and southern hemisphere influenza seasons annually.1,2

The First Quadrivalent Influenza Vaccine Indicated for Maternal Immunisation and Passive Protection of Newborns Up To 6 Months of Age#*5

*Not all infants may be protected.

VAXIGRIPTETRA MY PI

www.sanofi.com.my/products/vaxigriptetra

For the full prescribing information, please scan the QR code or visit the link provided.

* Not all infants are protected.
# In Malaysia. Accessed as at 19 December 2022, 2022 verified. Influenza Vaccines Registered in Malaysia. Available at Sistem Pendaftaran Produk & Perlesenan https://quest3plus.bpfk.gov.my/pmo2/index.php.

References

  1. World Health Organization. Recommendations announced for influenza vaccine composition for the 2022-2023 northern hemisphere influenza season. Available at https://www.who.int/news/item/25-02-2022-recommendations-announced-for-influenza-vaccine-composition-for-the-2022-2023-northern-hemisphere-influenza-season. Accessed on 9 December 2022.
  2. World Health Organization. New recommendations for the composition of influenza vaccines in 2023 for the southern hemisphere. Available at https://www.who.int/news/item/23-09-2022-new-recommendations-for-the-composition-of-influenza-vaccines-in-2023-for-the-southern-hemisphere. Accessed on 19 December 2022.
  3. VaxigripTetra® Influenza Vaccine [Summary of Product Characteristics]. Data on file. Sanofi Pasteur Inc.
  4. Fröbert O, Götberg M, Erlinge D, et al. Influenza vaccination after myocardial infarction: A randomized, double-blind, placebo-controlled, multicenter trial. Circulation. 2021;144(18):1476-1484. doi:10.1161/CIRCULATIONAHA.121.057042.
  5. Omer SB, Clark DR, Madhi SA, et al. Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: A pooled analysis of three randomised controlled trials. Lancet Respir Med. 2020;8:597-608. doi:10.1016/S2213-2600(19)30479-5.
  6. Pepin S, Samson SI, Alvarez FP, et al. Impact of a quadrivalent inactivated influenza vaccine on influenza associated complications and health care use in children aged 6 to 35 months: Analysis of data from a phase III trial in the northern and southern hemispheres. Vaccine. 2019;37(13):1885-1888. doi:10.1016/jvaccine.2019.01.059.
  7. Sanofi. Periodic Benefit Risk Evaluation Report. 4 May, 2020. Data on file
  8. Sesay S, et al. Hum Vaccin Immunother. 2018;14(3):596-608.

Get a copy of this article for offline reading:

Download

Related articles
MAT-MY-2300518-1.0-09/23